These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 16780934

  • 1. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Campo E, Pahisa J, Ordi J.
    Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
    [Abstract] [Full Text] [Related]

  • 2. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
    Mo LZ, Song HL, Wang JL, He Q, Qiu ZC, Li F.
    Asian Pac J Cancer Prev; 2015 Nov; 16(10):4297-302. PubMed ID: 26028089
    [Abstract] [Full Text] [Related]

  • 3. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
    Niu XY, Feng YK.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
    [Abstract] [Full Text] [Related]

  • 4. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Kong TW, Son JH, Chang SJ, Paek J, Lee Y, Ryu HS.
    Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
    [Abstract] [Full Text] [Related]

  • 5. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
    Wu D, Zheng Y, Chen W, Guo C, Yu J, Chen G, Huang Y.
    Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N, Schwarz J, Choschzick M, Jaenicke F, Gieseking F, Issa R, Mahner S, Woelber L.
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [Abstract] [Full Text] [Related]

  • 9. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
    Houfflin Debarge V, Collinet P, Vinatier D, Ego A, Dewilde A, Boman F, Leroy JL.
    Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
    Du R, Meng W, Chen ZF, Zhang Y, Chen SY, Ding Y.
    Eur J Gynaecol Oncol; 2013 Sep; 34(6):548-51. PubMed ID: 24601049
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia.
    Ruano Y, Torrents M, Ferrer FJ.
    Eur J Gynaecol Oncol; 2015 Sep; 36(3):245-51. PubMed ID: 26189247
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
    Kang WD, Kim SM.
    Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
    [Abstract] [Full Text] [Related]

  • 14. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
    Almog B, Gamzu R, Kuperminc MJ, Levin I, Fainaru O, Niv J, Bar-Am A.
    Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
    [Abstract] [Full Text] [Related]

  • 15. Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions.
    Prato B, Ghelardi A, Gadducci A, Marchetti I, Di Cristofano C, Di Coscio G, Bevilacqua G, Genazzani AR.
    Int J Gynecol Cancer; 2008 Mar; 18(1):90-4. PubMed ID: 17506849
    [Abstract] [Full Text] [Related]

  • 16. A human papillomavirus (HPV)-16 or HPV-18 genotype is a reliable predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3.
    Kang WD, Ju UC, Kim SM.
    J Gynecol Oncol; 2016 Jan; 27(1):e2. PubMed ID: 26463431
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Liu L, Chen LM, Tao X, Dai F, Guo LP, Zhang HW, Zhou XR, Sui L.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):751-756. PubMed ID: 29179270
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.